RecruitingNot ApplicableNCT04699734

Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy

Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy: How Important is the Peripheral Signaling?

Sponsor

University of Aarhus

Enrollment

16 participants

Start Date

Sep 8, 2020

Study Type

INTERVENTIONAL

Conditions

Neuropathy;Peripheral Painful Diabetic Neuropathy Neuropathic Pain

Summary

The purpose of the present study is to evaluate the role of peripheral afferent input for spontaneous pain in painful diabetic polyneuropathy

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying NaCl 9mg/ml and Xylocaine 1% for people with neuropathic pain, neuropathy;peripheral, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTXylocaine 1%

Nerve block

DIAGNOSTIC_TESTNaCl 9mg/ml

Nerve block

Locations(1)

Danish Pain Research Center, Aarhus University, Aarhus University Hospital

Aarhus N, Jutland, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04699734

Related Trials

Efficacy of an Intraoperative Periradicular Application of Platelet Rich Fibrin (PRF) on the Intensity of Residual Post-surgical Neuropathic Pain After a Surgery for Disc Herniation

NCT051965031 location

Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study

NCT058113121 location